Aglaris Ltd
Aglaris specializes in advancing gene and cell therapies by addressing manufacturing challenges. They focus on providing confident quality, consistency, and scalability in cell-based therapies with their innovative bioreactor Facer 1.0. The company is committed to technological progress and enhancing customer experience, with plans to expand their website and services.
Industries
biotechnology
health-care
manufacturing
medical
Nr. of Employees
small (1-50)
Products
Bioreactor system for cell-based therapy manufacturing (prototype product)
A bioreactor platform developed to address quality, consistency, and scalability challenges in the manufacturing of cell-based therapies.
Bioreactor system for cell-based therapy manufacturing (prototype product)
A bioreactor platform developed to address quality, consistency, and scalability challenges in the manufacturing of cell-based therapies.
Services
Provision of a bioreactor platform and associated manufacturing optimization intended to improve quality, consistency, and scalability of cell-based therapy production.
Provision of a bioreactor platform and associated manufacturing optimization intended to improve quality, consistency, and scalability of cell-based therapy production.
Expertise Areas
- Cell therapy manufacturing
- Bioreactor engineering
- Process scale-up for cell-based therapeutics
- Manufacturing quality and reproducibility
Key Technologies
- Bioreactor systems for cell therapy manufacturing
- Process scale-up methodologies for cell production
- Manufacturing quality-control practices for biologics